SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-21-005122
Filing Date
2021-03-01
Accepted
2021-03-01 17:00:06
Documents
81
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 2416991
2 ex4-6.htm EX-4.6 28977
3 ex10-1.htm EX-10.1 325755
4 ex21-1.htm EX-21.1 3689
5 ex23-1.htm EX-23.1 7415
6 ex31-1.htm EX-31.1 11757
7 ex31-2.htm EX-31.2 10849
8 ex32-1.htm EX-32.1 6478
9 ex32-2.htm EX-32.2 6435
  Complete submission text file 0001493152-21-005122.txt   6324708

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE ogen-20201231.xml EX-101.INS 601098
11 XBRL SCHEMA FILE ogen-20201231.xsd EX-101.SCH 63093
12 XBRL CALCULATION FILE ogen-20201231_cal.xml EX-101.CAL 63443
13 XBRL DEFINITION FILE ogen-20201231_def.xml EX-101.DEF 209092
14 XBRL LABEL FILE ogen-20201231_lab.xml EX-101.LAB 397944
15 XBRL PRESENTATION FILE ogen-20201231_pre.xml EX-101.PRE 311113
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32188 | Film No.: 21698967
SIC: 2834 Pharmaceutical Preparations